Nurse Practitioner, Family · Lake Elsinore, CA
NPI
1902150865
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
31736 Mission Trl Ste G
Lake Elsinore, CA, 92530
Phone (951) 674-1505
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
2,839 prescriptions
Company payments, 2025
$1,570
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug Anna Marie Soriano-Samson prescribed most often to Medicare patients was Ozempic (Semaglutide), with 464 prescriptions and refills. In total Anna Marie Soriano-Samson wrote 2,839 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 464 | 542 | 105 | $498K |
| Jardiance Empagliflozin | 383 | 535 | 101 | $303K |
| Farxiga Dapagliflozin Propanediol | 262 | 381 | 92 | $205K |
| Trulicity Dulaglutide | 141 | 166 | 27 | $155K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 97 | 225 | 50 | $21K |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 178 | 35 | $29K |
| Metformin Hcl Generic | 80 | 225 | 38 | $834 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 68 | 164 | 37 | $9,681 |
| Mounjaro Tirzepatide | 65 | 70 | 16 | $73K |
| Rybelsus Semaglutide | 61 | 75 | 20 | $69K |
| Fenofibrate Generic | 57 | 153 | 29 | $1,116 |
| Januvia Sitagliptin Phosphate | 53 | 77 | 14 | $38K |
| Dapagliflozin Dapagliflozin Propanediol | 50 | 70 | 19 | $36K |
| Atorvastatin Calcium Generic | 43 | 115 | 17 | $896 |
| Levothyroxine Sodium Generic | 42 | 100 | 19 | $381 |
Brand drugs: 2,190 claims; generic drugs: 426 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Marie Soriano-Samson $1,570 ($1,570 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbott Laboratories with $252.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 11 | $252 |
| Xeris Pharmaceuticals, Inc. | 10 | $209 |
| Insulet Corporation PODD | 15 | $207 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $155 |
| Medtronic, Inc. MDT | 4 | $108 |
| Ascensia Diabetes Care Us Inc. | 4 | $101 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $85.64 |
| Lilly USA, LLC LLY | 3 | $77.83 |
| Sequel Med Tech, LLC | 2 | $53.77 |
| Recordati_rare_diseases_inc. | 2 | $53.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.